Latvia vs Malta: Number of isolates tested for ceftriaxone
Latvia
7
in 2019
Malta
5
in 2020
Latvia rank
50th
Malta rank
51st
Number of isolates tested for ceftriaxone over time
- Latvia
- Malta
How they compare
Latvia currently reports 7 against 5 in Malta, a difference of 2.
That makes Latvia's figure about 1.4 times Malta's.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was Malta ahead.
Latvia ranks 50th and Malta ranks 51st of 52 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9 | 22 | 13 | Malta |
| 2010s | 18.88 | 24.38 | 5.5 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Latvia or Malta?
- Latvia, at 7 against 5 in Malta as of 2019.
- What is the difference in number of isolates tested for ceftriaxone between Latvia and Malta?
- 2, with Latvia ahead.
- How many years of comparable data are there for Latvia and Malta?
- 9 years are reported by both, from 2009 to 2018.
- How do Latvia and Malta rank globally for number of isolates tested for ceftriaxone?
- Latvia ranks 50th and Malta ranks 51st of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.